Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walter

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
CNS Drugs|March 19, 2014
Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activityMarcelo E Bigal, Sarah Walter
Current Pain and Headache Reports|March 11, 2015
TEV-48125: a review of a monoclonal CGRP antibody in development for the preventive treatment of migraineSarah Walter, Marcelo E Bigal
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 21, 2024
"Make research more people-centered": Two ADNI participants share recommendations for more inclusive Alzheimer's disease researchSarah Walter, Rochelle Long, Cynthia Huling Hummel
Headache|April 5, 2014
The vasodilatory activity of CGRP: a responseMarcelo E Bigal, Sarah Walter, Alan M Rapoport
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 28, 2022
Supporting participants and study partners when trials end as plannedSarah Walter, Emily A Largent, Rebecca M Edelmayer
Headache|July 16, 2013
Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of developmentMarcelo E Bigal, Sarah Walter, Alan M Rapoport
British Journal of Clinical Pharmacology|January 24, 2015
Therapeutic antibodies against CGRP or its receptorMarcelo E Bigal, Sarah Walter, Alan M Rapoport
Expert Review of Neurotherapeutics|May 3, 2019
Fremanezumab as a preventive treatment for episodic and chronic migraineMarcelo E Bigal, Sarah Walter, Alan M Rapoport
Mabs|May 29, 2014
Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptideSarah Walter, Abbas Alibhoy, Rafael Escandon, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|June 12, 2026
Research should be conducted with us, not on us: Perspectives on Alzheimer's disease clinical trials for persons with Down syndromeGreta Foye, Erika Foye, Sarah Walter, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
CNS Drugs|March 19, 2014
Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activityMarcelo E Bigal, Sarah Walter
Current Pain and Headache Reports|March 11, 2015
TEV-48125: a review of a monoclonal CGRP antibody in development for the preventive treatment of migraineSarah Walter, Marcelo E Bigal
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 21, 2024
"Make research more people-centered": Two ADNI participants share recommendations for more inclusive Alzheimer's disease researchSarah Walter, Rochelle Long, Cynthia Huling Hummel
Headache|April 5, 2014
The vasodilatory activity of CGRP: a responseMarcelo E Bigal, Sarah Walter, Alan M Rapoport
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 28, 2022
Supporting participants and study partners when trials end as plannedSarah Walter, Emily A Largent, Rebecca M Edelmayer
Headache|July 16, 2013
Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of developmentMarcelo E Bigal, Sarah Walter, Alan M Rapoport
British Journal of Clinical Pharmacology|January 24, 2015
Therapeutic antibodies against CGRP or its receptorMarcelo E Bigal, Sarah Walter, Alan M Rapoport
Expert Review of Neurotherapeutics|May 3, 2019
Fremanezumab as a preventive treatment for episodic and chronic migraineMarcelo E Bigal, Sarah Walter, Alan M Rapoport
Mabs|May 29, 2014
Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptideSarah Walter, Abbas Alibhoy, Rafael Escandon, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|June 12, 2026
Research should be conducted with us, not on us: Perspectives on Alzheimer's disease clinical trials for persons with Down syndromeGreta Foye, Erika Foye, Sarah Walter, et al.
Pageof 6